How ex vivo lung perfusion could play a significant role to decrease the incidence of renal injuries after lung transplantation?

Transplantation Technologies & Research

ISSN: 2161-0991

Open Access

How ex vivo lung perfusion could play a significant role to decrease the incidence of renal injuries after lung transplantation?

4th Global Surgery and Transplantation Congress

October 03-04, 2016 Atlanta, USA

Mohamed Shehata

Essen University Hospital, Germany

Posters & Accepted Abstracts: J Transplant Technol Res

Abstract :

Lung transplantation is indicated for terminal stage lung diseases such as chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, cystic fibrosis, pulmonary hypertension and sarcoidosis, which have a significant impact on the pulmonary vasculature and may affect the function of the right ventricle and cardiac output. Accordingly, right ventricular and correspondingly the left ventricular parameters and functions have been reported to improve after lung transplantation. However, improved cardiac index, echocardiography and other cardiovascular parameters are not the only indicators of good prognosis. Renal functions may, in addition, provide more reliable clinical prognostic evaluation. When the cardiac output is improved, following lung transplantation, renal perfusion and the urine output would correspondingly improve. However, if renal injury develops, urine output would not be able to reflect the improvement of the cardiac functions and the cardiovascular system may instead be affected secondary to the renal injury. High rates of incidence of acute and chronic kidney injuries have been reported following lung transplantation; with complete recovery from the acute kidney injury did not decrease the risk for the development of chronic kidney disease or long term mortality. Though renal injury following lung transplantation depends on many risk factors, including the original status of the patient's kidneys and the effects of the immuno-suppression, especially calcineurin inhibitor therapy, the increased production of inflammatory cytokines due to the ischemic reperfusion injury and the donor-recipient contact can be propagated to significant levels that lead to renal and other organs injury, dysfunction and or failure. In addition, reducing the pro-inflammatory stimuli associated with lung transplantation, may affect the long term immuno-suppression regime. Hence, effective EVLP might, to some degree, affect the risk of acute and or chronic kidney injuries following lung transplantation. Taking these concepts into consideration, a nonrandomized retrospective study has been recently reported by the Toronto team to compare 52 standard lung transplants to 13 EVLP transplants regarding the incidence of acute kidney injury following transplantation. The results showed no significant differences.

Biography :


Google Scholar citation report
Citations: 223

Transplantation Technologies & Research received 223 citations as per Google Scholar report

Transplantation Technologies & Research peer review process verified at publons

Indexed In

arrow_upward arrow_upward